Use the Back button in your browser to see the other results of your search or to select another record.
| A very early rehabilitation trial after stroke (AVERT): a phase III, multicentre, randomised controlled trial [with consumer summary] |
| Langhorne P, Wu O, Rodgers H, Ashburn A, Bernhardt J, on behalf of the AVERT triallists' collaboration |
| Health Technology Assessment (Winchester, England) 2017 Sep;21(54):1-120 |
| clinical trial |
| 8/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
Copyright release for this abstract has not been granted.
|